Results 191 to 200 of about 56,351 (295)

Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

Ibrain, Volume 12, Issue 1, Page 65-85, Spring 2026.
Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley   +1 more source

Progress in Gastroparesis Management: From Pharmacotherapy to Interventional Treatments

JGH Open, Volume 10, Issue 3, March 2026.
ABSTRACT Gastroparesis is a sensorimotor condition characterized by delayed gastric emptying without any obvious mechanical obstruction. Common symptoms include early satiety, nausea, vomiting, belching, and bloating. The most frequent causes of gastroparesis are diabetes, idiopathic factors, and post‐surgical complications.
Ganesh Kumar, Yash Shah, Ume Rooman, Ravi Patel, Shireen Asifa, Qais M. Salah, Dushyant Singh Dahiya, Arkadeep Dhali, Camelia Arsene, Meer Ali   +9 more
wiley   +1 more source

Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]

Curr Top Behav Neurosci
Bedillion MF, Moore CF, Weerts EM, Arout CA, Harris HM, Haney M.   +5 more
europepmc   +1 more source

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids 2.0. [PDF]

Biomedicines
Raup-Konsavage WM.
europepmc   +1 more source

The Roles of Motivation, Opportunity, and Ability on Willingness‐To‐Pay for Cannabis‐Infused Edibles in Hospitality Establishments and the Mediating Role of Involvement

International Journal of Tourism Research, Volume 28, Issue 2, March/April 2026.
ABSTRACT As Canadian cannabis legalization evolves, hospitality stakeholders are exploring integrating cannabis‐infused edibles into dining experiences. Despite regulatory prohibitions, sustained consumer interest suggests market opportunities, warranting examination of its drivers.
Michael Yu, Pengsongze Xue, Hwan‐Suk Choi   +2 more
wiley   +1 more source

Long‐Term Follow‐Up of Patients with Mass Social Media‐Induced Illness Presenting with Functional Tic‐like Behaviors

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 737-747, March 2026.
Abstract Background Only little is known about the prognosis of functional tic‐like behaviors (FTLB), especially in the subgroup of patients with mass social media‐induced illness (MSMI‐FTLB). Objectives To provide data of long‐term follow‐up (FU) of a carefully characterized group of patients with MSMI‐FTLB to identify influencing factors such as ...
L. Kathrin Hartung, Simon Schmitt, Carolin Fremer, Carolin S. Klages, Natalia Szejko, Kirsten R. Müller‐Vahl   +5 more
wiley   +1 more source

Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. [PDF]

Pharmaceuticals (Basel)
Marques BL, Lirio PHC, Vicente MA, Unzueta-Larrinaga P, Urigüen L, Campos AC.   +5 more
europepmc   +1 more source

Safety and Tolerability of Xanthohumol in Adults With Crohn's Disease: Results of a Triple‐Masked, Randomized, Placebo‐Controlled Phase 2 Trial

Molecular Nutrition &Food Research, Volume 70, Issue 6, 29 March 2026.
Adults with active Crohn's disease (n = 20) received 24 mg/day of xanthohumol (XN), a bioactive compound derived from Humulus lupulus (hops), for 8 weeks. The study evaluated safety and tolerability through clinical laboratory measures, adverse events, vital signs, anthropometrics, health−related quality of life, and adherence.
Ryan Bradley, Carina A. Staab, Paige E. Jamieson, Blake O. Langley, Thomas O. Metz, Jan F. Stevens   +5 more
wiley   +1 more source

Cannabinoid and cannabinoid related receptors in fibroblasts, inflammatory and endothelial cells of the equine hoof with and without laminitis: novel pharmacological target. [PDF]

Front Vet Sci
Zamith Cunha R, Gobbo F, Morini M, Salamanca G, Zanoni A, Bernardini C, Gramenzi A, Chiocchetti R.   +7 more
europepmc   +1 more source

Cannabinoid CB2 receptor [PDF]

Science-Business eXchange, 2008
openaire   +1 more source